Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Construct winning strategies that anticipate where value will lie. In Vivo’s in-depth analysis spans influential deals, R&D, commercial and market access strategies.
How it helps
With In Vivo, you’ll benefit from:
Incisive projections of future industry advances
Analysis of trends shaping the market landscape
Access interviews with leading decision makers, industry experts and thought leaders, across the industry.
Put your questions about any of our news stories, data and analysis to our expert journalists and analysts.
What's successful, what are the trends
In Vivo
By John Hodgson 16 Sep 2017
As a new generation of biosimilars challenge some of pharma’s biggest-selling products, this In Vivo analysis looks at how the originator blockbuster might fare in the face of competition.
Topic Biosimilars
Scrip, In Vivo, Pink Sheet, Medtech Insight
07 Sep 2017
What actually keeps biopharma execs up at night? Take our quiz to find out.
Topic Deal trends Diseases Drug development landscape FDA Medtech Personalized Medicine Parkinsons disease Reimbursement
In Vivo
By William Looney 03 Aug 2017
With 70 clinical trials now underway on a “next generation” of more precisely targeted antibody drug conjugates, In Vivo profiles Ambrx and Sutro Biopharma, two smaller biotechs with promising technologies and powerful partners.
Topic Cancer
In Vivo
02 Aug 2017
Oncology Innovation: lots of drugs, lots of trials, sometimes not enough patients.
Topic Cancer
Trialtrove, In Vivo
13 Jul 2017
Imagine a world where you can print out your own medicine at home...
Topic Personalized Medicine
In Vivo
By Peter Charlish 10 Jul 2017
Liquid biopsies look set to revolutionize the management of cancer patients. A significant application could come in immuno-oncology.
Topic Cancer Business strategies
In Vivo
26 Jun 2017
The essential information in this free video comes to you from In Vivo, part of the Informa Pharma Intelligence suite of tools.
Topic Personalized Medicine
In Vivo
By Doro Shin 05 Jun 2017
Success rates are higher for clinical trials that incorporate selective pharmacogenomics and pharmacogenetics (PGX) biomarkers, according to data from Informa's Trialtrove.
Topic Personalized Medicine
In Vivo
By William Looney 04 Jun 2017
Personalized medicine is focused on meeting patients’ needs, but it also has the potential to transform the delivery and financing of health care.
Topic Personalized Medicine
In Vivo
By Michael Swanick 04 Jun 2017
The shifts roiling the health care industry are creating an entirely new commercial landscape. PwC says that the way pharma companies opt to address three pivotal challenges
Topic Personalized Medicine
In Vivo
By Peter Charlish 04 Jun 2017
Flatiron Health was formed to exploit a previously untapped source of real-world data on the treatment and clinical outcomes of cancer patients.
Topic Personalized Medicine
In Vivo
By Melanie Senior 04 Jun 2017
Patient-centric R&D is imperative for pharma in delivering effective medicines and better outcomes.
Topic Personalized Medicine
In Vivo
By Peter Charlish 04 Jun 2017
Singulex and Qiagen have entered a strategic alliance whereby Qiagen will be able to offer its clients companion diagnostic development services.
Topic Personalized Medicine
In Vivo
By Melanie Senior 04 Jun 2017
Artificial intelligence won’t transform pharma R&D, at least not anytime soon. But it is already impacting health care delivery and clinical trials.
Topic Personalized Medicine
In Vivo
By John Hodgson 17 May 2017
Oncology innovation: lots of drugs, lots of trials, sometimes not enough patients. And styles of innovation depend on whether a company has a big franchise to defend or would like one. In Vivo presents current data on sales, pipelines, trials and fails.
Topic Personalized Medicine
In Vivo
20 Sep 2017
In Vivo
18 Sep 2017
In Vivo
13 Sep 2017
In Vivo
13 Sep 2017
In Vivo
11 Sep 2017
In Vivo
11 Sep 2017
In Vivo
11 Sep 2017
In Vivo
04 Sep 2017
In Vivo
04 Sep 2017
In Vivo
04 Sep 2017
In Vivo
04 Sep 2017
In Vivo
04 Sep 2017
In Vivo
30 Aug 2017
In Vivo
28 Aug 2017
In Vivo
28 Aug 2017
Connecticut
Amanda specializes in
+17 year(s) experience
Connecticut
Beth specializes in
+16 year(s) experience
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
